IDT enters clinical diagnostics market with in vitro diagnostic launch
Integrated DNA Technologies (IDT) has announced its first in vitro diagnostic offerings, Archer FUSIONPlex-HT Dx and VARIANTPlex-HT Dx, utilizing proprietary AMP chemistry for targeted sequencing, streamlining library prep with user-friendly reagents and parallel workflow steps.
Integrated DNA Technologies (IDT) has unveiled the company’s first in vitro diagnostic (IVD) offerings: the Archer FUSIONPlex-HT Dx and VARIANTPlex-HT Dx.
VARIANTPlex-HT Dx and FUSIONPlex-HT Dx are built on IDT’s proprietary Anchored Multiplex PCR (AMP) chemistry for targeted DNA- and RNA-sequencing. Each kit includes color-coded, technician-and robot-friendly reagents, adapters, and magnetic cleanup beads. In addition, the workflow steps can run in parallel, enabling efficient, simple library preparation.
IDT will continue to expand on its Archer IVD solutions portfolio with future planned launches based on the foundational, easy-to-use anchored multiplex-PCR technology with the ultimate goal of open access to the full range of Archer NGS assay capabilities including novel fusion and complex variant detection for challenging sample types.
